Ovarian Cancer Drug Reduces Progression

In a recent clinical trial, an ovarian cancer drug called Lynparza significantly reduced the risk for disease progression. This medication belongs to a class of drugs called PARP—poly (ADP-ribose) polymerase—inhibitors, a type of targeted therapy tha...

How to Recognize Ovarian Cancer

More than 70 percent of women with ovarian cancer are diagnosed when the disease is in its advanced stages. Here’s what you should know.

More Cancers Linked to Weight

Obesity rates have more than doubled worldwide since 1980, according to the World Health Organization, to more than 600 million adults. For years, research has shown that people who are overweight or obese have an increased risk for heart disease, di...

Blood Test Could Detect Ovarian Cancer Sooner

A blood screening test could help detect ovarian cancer sooner, and that, according to new research published in The Lancet, could help lower its death rate by as much as 20 percent. Ovarian cancer now tends to be diagnosed at an advanced stage, with ...

More Resources